Generally, calcitonin (CT) values below the upper reference limit rule-out medullary thyroid
carcinoma (MTC) with very high accuracy. However, sparse cases of serum-calcitonin …

Purpose Medullary thyroid carcinoma (MTC) is a relatively uncommon malignant tumor of
the parafollicular C cells of the thyroid, which distinguishing feature is the production of …

Background Medullary thyroid carcinoma is a neuroendocrine tumor belonging form a
malignant growth of the thyroid parafollicular C-cells, representing from 1 to 10% of all …

Background: Medullary thyroid carcinoma (MTC) is characterized by the synthesis and
secretion of calcitonin (Ct). MTC without Ct secretion has been reported on rare occasions …

Introduction Medullary thyroid carcinoma (MTC) is a rare cancer that accounts for 5% of
thyroid cancers. Serum calcitonin is a good biomarker for MTC, which is used for diagnosis …

Context: Calcitonin is a sensitive biomarker that is used for diagnosis and follow-up in
medullary thyroid cancer (MTC). In patients with tumors> 1 cm, it is uncommon for …

Background: Serum Ca19. 9 positivity is a prognostic factor for mortality in patients with
advanced medullary thyroid cancer (aMTC), independently from calcitonin doubling time …

Background Medullary thyroid carcinoma is a malignant uncommon and aggressive tumour
of the parafollicular C cells. In about 75% of cases it is sporadic while, in case of RET …

Background and Objectives We aimed to evaluate the disease specific‐survival (DSS) of
patients with Medullary Thyroid Cancer (MTC) confined to the central neck based on the …

Medullary thyroid cancer (MTC) is the third frequent subtype of thyroid cancer-driving from
thyroid C-cells. The first-line strategy to treat MTC is surgery, but tumor recurrence and …